Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP-Reference-Cited by-同舟云学术

Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R‐CHOP

Published:2020-07 Issue:1 Volume:1 Page:170-180
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Procházka Vít¹^ORCID,Belada David²^ORCID,Janíková Andrea³^ORCID,Benešová Kateřina⁴^ORCID,Mociková Heidi⁵^ORCID,Ďuraš Juraj⁶,Pirnos Jan⁷,Kopečková Kateřina⁸,Campr Vít⁹¹⁰,Fürst Tomáš¹¹^ORCID,Pytlík Robert⁴^ORCID,Sýkorová Alice²^ORCID,Michalka Jozef³^ORCID,Dlouhá Jitka⁴,Papajík Tomáš¹^ORCID,Trněný Marek⁴^ORCID

Affiliation:

1. Department of Hemato‐Oncology, Faculty of Medicine and DentistryUniversity Hospital in Olomouc Olomouc Czech Republic

2. Fourth Department of Internal Medicine – HematologyUniversity Hospital Hradec Králové Czech Republic

3. Department of Hematology and OncologyMasaryk University Hospital Brno Brno Czech Republic

4. First Department of Internal Medicine – HematologyFirst Faculty of Medicine and General Teaching Hospital Prague Czech Republic

5. Department of Internal Medicine and Hematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of MedicineCharles University Prague Czech Republic

6. Department of Hemato‐OncologyUniversity Hospital Ostrava Ostrava Czech Republic

7. Department of OncologyHospital České Budějovice České Budějovice Czech Republic

8. Department of OncologyUniversity Hospital Motol Prague Czech Republic

9. Department of Pathology and Molecular MedicineUniversity Hospital in Motol Prague Czech Republic

10. Second Faculty of MedicineCharles University Prague Czech Republic

11. Department of Mathematical Analysis and Applications of Mathematics, Faculty of SciencePalacký University Olomouc Czech Republic

Funder

Ministry of Health, Czech Republic

Charles University PROGRES

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.60

Reference34 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

3. Follicular lymphoma: 2018 update on diagnosis and management

4. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up;Dreyling M;Ann Oncol,2016

5. NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019